SCHEMBL29964360

SCHEMBL29964360

Cc1nc2cccc(F)c2c(=O)[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 1.00
TYMS P04818 10/20 0.55
TNKS2 Q9H2K2 2/20 0.54
TNKS O95271 1/20 0.53
ADORA3 P0DMS8 1/20 0.49
BMPR1B O00238 1/20 0.47
RAF1 P04049 1/20 0.47
BRAF P15056 1/20 0.47
BMPR1A P36894 1/20 0.47
ACVR1B P36896 1/20 0.47
TGFBR1 P36897 1/20 0.47
ACVRL1 P37023 1/20 0.47
ACVR1 Q04771 1/20 0.47
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2659299 1.00 PARP1 (1.00) PARP1TYMSTNKS2TNKSADORA3
SCHEMBL30838794 0.82 PARP1 (1.00) PARP1TYMSTNKS2BMPR1BRAF1
SCHEMBL9259148 0.82 PARP1 (1.00) PARP1TYMSTNKS2BMPR1BRAF1
SCHEMBL578200 0.79 PARP1 (0.66) PARP1TYMSTNKS2TNKSMMP13
SCHEMBL15840736 0.79 PARP1 (0.66) PARP1TYMSTNKS2TNKSADORA3
SCHEMBL30704850 0.79 PARP1 (1.00) PARP1TYMSTNKS2TNKSBMPR1B
SCHEMBL328456 0.79 PARP1 (0.70) PARP1TYMSTNKS2BMPR1BRAF1
SCHEMBL12169915 0.79 PARP1 (1.00) PARP1TYMSTNKS2TNKSBMPR1B
SCHEMBL30395697 0.79 PARP1 (0.66) PARP1TYMSTNKS2TNKSNPC1
SCHEMBL29442253 0.79 PARP1 (0.70) PARP1TYMSTNKS2BMPR1BRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
CN-117597336-A Halogen substituted amino aza-heteroaryl compounds as inhibitors of hematopoietic progenitor kinase 1 (HPK 1) 安大略省癌症研究所(OICR) 2024-02-23 CN disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 PARP1 2516/4885TYMS 1583/4885TNKS2 467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.